Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2012
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2514918C Method to confer cell culture replication activity to different hepatitis c virus isolates
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2336227C Genes involved in tolerance to environmental stress
07/03/2012CA2330618C Viral chimeras comprised of caev and hiv-1 genetic elements
07/03/2012CA2315294C Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2296711C Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
07/03/2012CA2196555C Vr-2332 viral nucleotide sequence and methods of use
07/02/2012CA2806314A1 Method for purifying active polypeptides or immunoconjugates
06/2012
06/28/2012WO2012088446A1 Superagonists and antagonists of interleukin-2
06/28/2012WO2012088342A1 Plant gene expression modulatory sequences from maize
06/28/2012WO2012088165A1 Thermostable c. bescii enzymes
06/28/2012WO2012088123A1 Polymer-factor vii moiety conjugates
06/28/2012WO2012088041A1 Adenoviral vector-based dengue fever vaccine
06/28/2012WO2012088006A1 Fibronectin based scaffold domain proteins that bind il-23
06/28/2012WO2012087943A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
06/28/2012WO2012087912A1 Her2 binding peptides labelled with a 18f - containing organosilicon compound
06/28/2012WO2012087908A1 Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
06/28/2012WO2012087903A2 Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides
06/28/2012WO2012087231A1 Affinity chromatography matrix
06/28/2012WO2012087230A1 Affinity chromatography matrix
06/28/2012WO2012087160A2 Anti-inflammatory proteins and methods of preparation and use thereof
06/28/2012WO2012087039A2 Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same
06/28/2012WO2012087038A2 Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same
06/28/2012WO2012087017A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
06/28/2012WO2012086428A1 Medicinal composition comprising calmodulin-like skin protein as active ingredient
06/28/2012WO2012086391A1 Information acquisition method
06/28/2012WO2012085891A2 Tnf family ligand variants
06/28/2012WO2012085861A1 Reagentless fluorescent biosensors from nanofitins, rational design methods to create reagentless fluorescent biosensors and methods of their use
06/28/2012WO2012085642A1 Vaccines with live bacterial isolates for systemic administration
06/28/2012WO2012085279A2 Method for cross-linking peptides
06/28/2012WO2012085178A1 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
06/28/2012WO2012085146A1 Method for producing apolipoprotein in plants
06/28/2012WO2012084715A1 Disruption of ahp6 gene leads to plants with improved seed yield
06/28/2012WO2012084272A1 Oprf/i agents and their use in hospitalized and other patients
06/28/2012WO2012083837A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
06/28/2012WO2012083580A1 Method for purifying human serum albumin from transgenic rice grain
06/28/2012WO2012083579A1 Method for extracting human serum albumin from transgenic rice grain
06/28/2012WO2012083547A1 Anti-verticillium wilt gene of gossypium barbadense and its use
06/28/2012WO2012083475A1 Neutralizing polyclonal antibody against hantavirusandes, production method and pharmaceutical compositions
06/28/2012WO2012083445A1 Virus like particle production in plants
06/28/2012WO2012083425A1 Novel alkali-resistant variants of protein a and their use in affinity chromatography
06/28/2012WO2012059873A3 Anti-diabetic compounds
06/28/2012WO2012058616A3 Engineered kinetochores and uses thereof
06/28/2012WO2012057529A3 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
06/28/2012WO2012055986A9 Methods for capturing virus like particles from plants using expanded bed chromatography
06/28/2012WO2012052158A3 Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid
06/28/2012WO2012051055A3 Variant cbh i polypeptides
06/28/2012WO2012039559A3 Tofi variant proteins and method for producing the same
06/28/2012WO2012037397A3 Step-derived peptide for brain injury treatment
06/28/2012WO2012032068A3 Compounds and methods
06/28/2012WO2012028309A3 Heavy metal reduction in planta
06/28/2012WO2012010946A3 Bnip3 isoforms and methods of use
06/28/2012US20120167259 Novel bacillus thuringiensis gene with lepidopteran activity
06/28/2012US20120167247 Inhibition of bolting and flowering of a sugar beet plant
06/28/2012US20120167241 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
06/28/2012US20120167239 Novel ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
06/28/2012US20120167236 Method of predicting a behavior of one or more drugs
06/28/2012US20120165650 Her2 binders
06/28/2012US20120165510 novel application of fibrinogen-420 and its active domain
06/28/2012US20120165509 method for isolating and purifying recombinant human serum albumin from transgenic rice grain
06/28/2012US20120165508 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins
06/28/2012US20120165507 Mutant proteins and methods for producing them
06/28/2012US20120165506 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
06/28/2012US20120165505 Beta Helical Peptide Structures Stable in Aqueous and Non-Aqueous Media
06/28/2012US20120165503 Oxyntomodulin analogs
06/28/2012US20120165275 Nitrogen-Based Linkers for Attaching Modifying Groups to Polypeptides and Other Macromolecules
06/28/2012US20120165274 Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto
06/28/2012US20120165268 P53 fusion proteins and methods of making and using thereof
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165266 Method for preparing gintonin, which is a novel glycolipoproetin from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method
06/28/2012US20120165264 Degradation-Stabilised, Biocompatible Collagen Matrices
06/28/2012US20120165262 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
06/28/2012US20120165261 Alpha-1-antitrypsin compositions
06/28/2012US20120165259 Agent for ameliorating blood-brain barrier disorders
06/28/2012US20120165255 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/28/2012US20120165245 Angiogenically effective unit dose of fgf and method of administering
06/28/2012US20120165230 Biologically produced cyclic affinity tags
06/28/2012US20120165226 Phage display
06/28/2012US20120164729 Composition for culturing pluripotent stem cells and use thereof
06/28/2012US20120164710 Method of preparation of a biological particulate structure
06/28/2012US20120164664 T1r taste receptors and genes encoding same
06/28/2012US20120164660 Method for using a diagnostic agent which includes a calcium binding protein assay reagent and assay method for calcium binding protein
06/28/2012US20120164301 Production of acid soluble soy protein isolates ("s700")
06/28/2012US20120164234 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
06/28/2012US20120164229 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
06/28/2012US20120164196 Sericin cationic nanoparticles for application in products for hair and dyed hair
06/28/2012US20120164176 Rsv f protein compositions amd methods for making same
06/28/2012US20120164170 Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof
06/28/2012US20120164167 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164162 Methods in cell cultures, and related inventions, employing certain additives
06/28/2012US20120164147 Mammalian genes; related reagents and methods
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164141 Methods and compositions for inducing apoptosis
06/28/2012US20120164128 Means and methods for counteracting polyq expansion disorders
06/28/2012US20120164127 Mirac proteins